domingo, 30 de marzo de 2025

Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial

https://www.thelancet.com/collections/neurology?dgcid=hubspot_email_infocusalerts-neurology_feature&parent=001585&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-9QoxAmrt0D3ejRqtAYYWr9LGFF2VM09Jxpvnx_hdyV61OZe9YzcQnm1A5X3qz-YLA_RWXPw74EZ_uoifElT1Rp-_oyAQ&_hsmi=353495300&utm_content=353495300&utm_source=hs_email

No hay comentarios:

Publicar un comentario